6505--Abiraterone Acetate Tablets
ID: 36E79724R0023Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/b1755fdab6cb4b48b71d4836e11ec13e/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting offers for the supply of Abiraterone Acetate tablets, a pharmaceutical product critical for various government healthcare facilities, including the VA and DoD. The procurement aims to establish a reliable source through competitive contracting, requiring offerors to provide pricing for a base year and four option years, along with an NDC number for their products. Abiraterone Acetate is essential for treating specific cancers, underscoring the importance of ensuring consistent availability of this medication to support patient care. Interested vendors should contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further details, and must comply with specific packaging, labeling, and manufacturing standards as outlined in the solicitation document.

    Point(s) of Contact
    Richard MaharioContract Specialist
    Richard.Mahario@va.gov
    Files
    Title
    Posted
    36E79724R0023_1.docx
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) for the procurement of Abiraterone Acetate Tablets, identified by solicitation number 36E79724R0023. This procurement aims to secure a reliable supply for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare entities. The contract will span one year, with four possible one-year extensions, emphasizing uninterrupted supply and specific labeling requirements for each offeror. Interested vendors must identify unique National Drug Codes (NDC) and ensure compliance with packaging specifications, including dimensions and safety caps. The estimated annual needs include 71,997 bottles of 120-count 250mg tablets and 1,102 bottles of 60-count 500mg tablets. The RFP will be electronically released on approximately September 18, 2024, with a closing date of October 2, 2024. Offerors must check SAM.gov for updates, as no paper copies of the solicitation will be provided. For inquiries, potential bidders can contact Contract Specialist Richard Mahario via email or phone. This procurement reflects the VA's commitment to meeting the pharmaceutical needs of veterans and other designated agencies.
    36E79724R0023.docx
    The document outlines a solicitation from the Department of Veterans Affairs for pharmaceutical products, specifically Abiraterone Acetate tablets in two strengths. The purpose is to establish a supply source through competitive contracting for these drugs, with the contract expected to facilitate distribution to various government healthcare facilities, including the VA, DoD, and others. Offerors must submit pricing for the base year and four options and include an NDC number for their products. The contract includes stipulations such as a 0.5% Cost Recovery Fee and compliance with specific packaging and labeling standards, which include barcoding and adherence to the Drug Supply Chain Security Act. It emphasizes the requirement for pharmaceuticals to be manufactured in FDA-approved facilities and mandates specific reporting and invoicing procedures. The scope includes a detailed description of the contracting process, performance evaluations, and repercussions of noncompliance. This solicitation represents a structured effort to ensure consistent and reliable pharmaceutical supplies to government healthcare providers, ensuring compliance with regulations while promoting competition among vendors.
    Lifecycle
    Title
    Type
    6505--Abiraterone Acetate Tablets
    Currently viewing
    Solicitation
    6505--Abiraterone Acetate Tablets
    Presolicitation
    Similar Opportunities
    6505--Norethindrone 5mg Tablet (VA-25-00005551)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the supply of Norethindrone Acetate Tablets under Request for Proposal (RFP) 36E79724R0027. The procurement aims to establish contracts for the pharmaceutical product, with specific requirements regarding pricing for a base year and four option years, compliance with packaging standards, and adherence to the Drug Supply Chain Security Act (DSCSA) regulations. This medication is essential for various health treatments within the VA system, ensuring that veterans receive necessary pharmaceutical care. Interested contractors must submit their proposals by November 15, 2024, at 2:30 PM Central Standard Time, to the designated email addresses provided in the solicitation documents. For further inquiries, potential bidders can contact Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6509--Warfarin Tablets (VA-25-00012328)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0007 for the procurement of Warfarin Tablets, aimed at ensuring a reliable supply for various federal health agencies, including the Department of Defense and the Bureau of Prisons. This unrestricted procurement will cover multiple tablet strengths and packaging sizes, with an estimated annual usage detailed across 16 product types, and will be awarded for an initial one-year period with options for four additional years. The successful contractor must provide unique labeling and a National Drug Code (NDC) associated with their product, emphasizing the importance of compliance with federal regulations in pharmaceutical supply. Interested vendors should note that the solicitation will be electronically issued around November 13, 2024, with a response deadline of November 27, 2024; inquiries can be directed to Contract Specialist Adrienne Albachiara at adrienne.albachiara@va.gov.
    Bicalutamide 50MG tablets
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Bicalutamide 50MG tablets, available in bottle counts of 30 and 500. The procurement aims to establish a reliable national supply source for these pharmaceutical products, which are critical for various Department of Defense and other federal health programs. This unrestricted and fully competitive acquisition will be a firm-fixed price contract with a one-year base period and four one-year options, with the solicitation expected to be posted on the DLA Bid Board System and Sam.gov. Interested parties should direct inquiries to Keith Ryales at keith.ryales@dla.mil or call 215-737-9199 for further information.
    6505--Metformin SA Tablets REPACK PROGRAM
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Metformin HCL SA Tablets, aimed at ensuring a consistent supply for various governmental entities, including the VA, Department of Defense, Bureau of Prisons, and others. The procurement will cover a one-year contract with the possibility of four additional one-year extensions, requiring offerors to provide a unique National Drug Code (NDC) number and distinct labeling for the supplied products. This initiative is critical for maintaining the availability of essential pharmaceuticals, with estimated annual requirements detailed for two groups: Other Government Agencies and the VA Repack Program. The solicitation, numbered 36E79725R0003, is scheduled for electronic release on December 3, 2024, with a closing date of December 17, 2024. Interested parties can direct inquiries to Teresa Hussain at teresa.hussain@va.gov or by phone at 708-786-5852, and are encouraged to monitor SAM.gov for updates.
    6505--Verapamil Hydrochloride (HCL) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) National Acquisition Center is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0006 to procure Verapamil Hydrochloride (HCL) Tablets. This procurement aims to ensure an uninterrupted supply of the drug for various federal entities, including the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will have a duration of one year, with the potential for four additional one-year options, and the estimated annual requirements include specific dosages and quantities of the tablets. Interested vendors must submit their proposals by December 4, 2024, and are encouraged to check SAM.gov for updates regarding the solicitation. For inquiries, vendors can contact Contract Specialist Deborah Fassl at Deborah.Fassl@va.gov or by phone at 708-786-5894.
    6505-- Pegfilgrastim
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Pegfilgrastim, a critical pharmaceutical product, through its Pharmaceutical Prime Vendor (PPV) program. The objective of this solicitation is to establish a reliable supply chain for specified medications at competitive prices, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and promoting small business participation. Pegfilgrastim is essential for patients undergoing chemotherapy, as it helps to stimulate the production of white blood cells, thereby reducing the risk of infection. Interested offerors must submit proposals that include unique National Drug Codes (NDCs), pricing for a base year and four optional renewal years, and details on compliance with safety standards. For further inquiries, contact Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Lamotrigine Immediate Release (IR) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the supply of Lamotrigine Immediate Release (IR) Tablets as part of its Pharmaceutical Prime Vendor (PPV) Program. The objective of this procurement is to establish a reliable supply source for these pharmaceuticals, ensuring their availability and implementing volume-based pricing for various government agencies, including the Department of Defense and Indian Health Services. Compliance with the Drug Supply Chain Security Act, stringent packaging requirements, and adherence to FDA cGMP standards are critical components of this contract, which includes a base year and four option years. Interested bidders should contact Contract Specialist Ray Roldan at Raymond.Roldan@va.gov for further details and to submit their proposals.
    6505--Aspirin_Dipyridamole SA Capsules (VA-25-00011491)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting offers for the procurement of Aspirin 25MG/Dipyridamole 200MG Sustained Action Capsules under solicitation number VA-25-00011491. This procurement aims to ensure a reliable supply chain for pharmaceuticals critical to various governmental health agencies, including the Department of Defense and Indian Health Services, and requires offerors to submit pricing for a base year and four option years, along with a Cost Recovery Fee of 0.5%. Compliance with the Drug Supply Chain Security Act (DSCSA) and FDA manufacturing standards is mandatory, and contractors must adhere to stringent packaging and labeling guidelines while demonstrating past performance evaluations. Interested parties should contact Contract Specialist Youlanda Duggar at youlanda.duggar@va.gov for further details.
    Rabeprazole Sodium Delayed Release Tablets
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Rabeprazole Sodium Delayed Release Tablets. The tablets will be used for medical purposes and will be available in 30, 90, and 500 count bottles. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source to provide the tablets for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Interested parties should contact Phyllis Daraio for more information. The projected solicitation date is February 2020.